To date, more than 100 lawsuits have been filed in regard to the adverse effects after use of the drug Pradaxa, however, the FDA recently made the announcement that Pradaxa users did not find an increased risk of bleeding when compared to the use of warfarin. This announcement, however, has been met with much criticism, asthe FDA failed to statethat the comparable drug, warfarin, came with areversal agentto handle a situation where a bleeding emergency takes place.
Pradaxa, on the other hand,does not include an antidotewhich would be essential for anti-clotting and preventing severe and possibly fatal bleeds. If you or a loved one has suffered a serious bleed following the use of Pradaxa, Phillips Law Group is offering a Free Case Reviewto discuss your potential legal options.
Call 602-222-2222
Pradaxa was first approved for use in the United States in October 2010 to prevent strokes in patients with non-valvular atrial fibrillation.Atrial fibrillation is a health condition common in elderly patients.It causes the heart to beat irregularly, thus increasing an individuals chance of getting blood clots and suffering from a stroke.Pradaxa belongs to a class of medications called direct thrombin inhibitors, which work by blocking a clotting enzyme in the patients bloodstream.In some cases, the inhibition of the enzyme may work to the detriment of the patient.If a patient who has been taking Pradaxa suffers from a serious bleeding event, their blood can fail to clot.This can result in gastro-intestinal bleeds, causing the hospitalization of the patient and sometimes leading to the patient bleeding to death.
Similar to other blood-thinning drugs, Pradaxas benefit of reducing the chance of a debilitating or fatal stroke comes with the risk of internal bleeding.If you or a loved one has been using Pradaxa and has experienced any of the following symptoms, it is important that you contact your physician immediately:
Since its approval in 2010, Boehringer Ingelheim, the German pharmaceutical company that manufactures Pradaxa, has reported about 260 deaths related to the drug.In December 2011, the FDA announced that they were reviewing reports of serious internal bleeding in elderly patients who were prescribed the popular anti-coagulant.If you or a loved one has suffered from using Pradaxa, do not wait to contact the Pradaxa gastro-intestinal bleed lawyers at Phillips Law Group for a free and confidential case evaluation.
